Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flexcon is a privately held, family-owned manufacturer of pressure-sensitive films, adhesives, labels, tapes, and functional materials serving multiple end markets, including healthcare, pharmaceuticals, and medical devices. In healthcare, the company supplies medical-grade adhesive solutions for wearables, diagnostics, electrodes, skin-contact applications, and pharmaceutical and medical device labeling rather than developing therapeutics. Its notable healthcare technology includes the patented Flexcon Omni-Wave platform, a hydrogel-free conductive adhesive system for biomedical electrodes and wearable sensors. Flexcon operates globally with manufacturing, finishing, and distribution capabilities across North America, Europe, and Asia. For a biotech or medtech analyst, Flexcon is best understood as a commercial materials and component supplier enabling device, diagnostic, and pharmaceutical packaging applications, not as a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flexcon.